Novel Benchmark Scaling Method for First-in-Human Dose of CAR-T Therapies

被引：0
|
作者：
Zhu, Xu [1 ]
Stein, Andrew [1 ]
Pearson, David [2 ]
Price, Andrew [1 ]
Sohoni, Akash [1 ]
Barton, Nathaniel [1 ]
Bradshaw, Laura [1 ]
Pinzon-Ortiz, Maria [1 ]
Bu, Dexiu [1 ]
Engels, Boris [1 ]
机构：
[1] Novartis Inst Biomed Res, Cambridge, MA USA
[2] Novartis Pharma AG, Basel, Switzerland
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1124
引用
收藏
页码：524 / 524
页数：1
相关论文
共 50 条
  • [41] Exosomes in review: A new frontier in CAR-T cell therapies
    Wang, John S.
    Schellenberg, Samuel J.
    Demeros, Athena
    Lin, Adam Y.
    NEOPLASIA, 2025, 62
  • [42] A Review of CAR-T Combination Therapies for Treatment of Gynecological Cancers
    Olifirenko, Valentina
    Barlev, Nikolai A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [43] New potential safety signals for CAR-T cell therapies
    Reactions Weekly, 2022, 1916 (1) : 10 - 10
  • [44] Current challenges and emerging opportunities of CAR-T cell therapies
    Abreu, Teresa R.
    Fonseca, Nuno A.
    Goncalves, Nelio
    Moreira, Joao Nuno
    JOURNAL OF CONTROLLED RELEASE, 2020, 319 : 246 - 261
  • [45] CAR-T cell therapies for cancer: what novel technologies are being developed for toxicity data?
    Parol, Wiktoria
    Anderson, Georgina S. F.
    Chapman, Michael A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (04) : 241 - 244
  • [46] Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem
    Gatto, Lidia
    Franceschi, Enrico
    Di Nunno, Vincenzo
    Maggio, Ilaria
    Lodi, Raffaele
    Brandes, Alba Ariela
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (12) : 1333 - 1353
  • [47] Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study
    Yang, Junfang
    He, Jiaping
    Zhang, Xian
    Li, Jingjing
    Wang, Zhenguang
    Zhang, Yongliang
    Qiu, Liyuan
    Wu, Qionglu
    Sun, Zhe
    Ye, Xun
    Yin, Wenjie
    Cao, Wei
    Shen, Lianjun
    Sersch, Martina
    Lu, Peihua
    BLOOD CANCER JOURNAL, 2022, 12 (07)
  • [48] Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study
    Junfang Yang
    Jiaping He
    Xian Zhang
    Jingjing Li
    Zhenguang Wang
    Yongliang Zhang
    Liyuan Qiu
    Qionglu Wu
    Zhe Sun
    Xun Ye
    Wenjie Yin
    Wei Cao
    Lianjun Shen
    Martina Sersch
    Peihua Lu
    Blood Cancer Journal, 12
  • [49] Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997-2020)
    Ivica, Nikola A.
    Young, Colin M.
    HEALTHCARE, 2021, 9 (08)
  • [50] CAR-T cells, the first pharmaceutical cell therapy
    Laurence, Arian
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (05)
12345